ArticleIn vivo (Athens, Greece)

WNT/β-catenin Signaling and CD8+ Tumor-infiltrating Lymphocytes in Tremelimumab Plus Durvalumab for Advanced Hepatocellular Carcinoma.

Akifumi Kuwano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.